Activation of innate immune defense mechanisms contributes to polyomavirus BK-associated nephropathy

Kidney International

Volumn 81, Issue 1, 2012, Pages 100-111

  Ribeiro, Andrea ^a   Wörnle, Markus ^a   Motamedi, Nasim ^b   Anders, Hans J ^a   Gröne, Elisabeth F ^c   Nitschko, Hans ^b   Kurktschiev, Peter ^a   Debiec, Hanna ^d   Kretzler, Matthias ^e   Cohen, Clemens D ^a,c   Gröne, Hermann J ^f   Schlöndorff, Detlef ^a,g   Schmid, Holger ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Urgences Néphrologiques et Transplantation Rénale Hôpital Tenon 4   (France)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

immunology and pathology; renal tubular epithelial cells; transplantation

Indexed keywords

BETA INTERFERON; CHEMOKINE; CYTOKINE; DOUBLE STRANDED RNA; INFLAMMASOME; INTERLEUKIN 1BETA; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; RETINOIC ACID INDUCIBLE PROTEIN I; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 3; VIRUS DNA;

ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BK VIRUS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; EPITHELIUM CELL; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INNATE IMMUNITY; INTRACELLULAR SIGNALING; KIDNEY COLLECTING TUBULE; KIDNEY DISEASE; NUCLEOTIDE SEQUENCE; POLYOMAVIRUS BK ASSOCIATED NEPHROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 83655163719     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.311     Document Type: Article

References (59)

1. Hirsch HH. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant 2002; 2: 25-30. (Pubitemid 36306804)
2. Nickeleit V, Singh HK, Mihatsch MJ. Polyomavirus nephropathy: morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens 2003; 12: 599-605. (Pubitemid 38186750)
3. Funk GA, Gosert R, Comoli P et al. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant 2008; 8: 2368-2377.
4. Jiang M, Abend JR, Tsai B et al. Early events during BK virus entry and disassembly. J Virol 2009; 83: 1350-1358.
5. Meehan SM, Kraus MD, Kadambi PV et al. Nephron segment localization of polyoma virus large T antigen in renal allografts. Hum Pathol 2006; 37: 1400-1406. (Pubitemid 44584333)
6. Liptak P, Kemeny E, Ivanyi B. Primer: histopathology of polyomavirusassociated nephropathy in renal allografts. Nat Clin Pract Nephrol 2006; 2: 631-636. (Pubitemid 44655640)
7. Moriyama T, Marquez JP, Wakatsuki T et al. Caveolar endocytosis is critical for BK virus infection of human renal proximal tubular epithelial cells. J Virol 2007; 81: 8552-8562. (Pubitemid 47242828)
8. Comoli P, Binggeli S, Ginevri F et al. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis 2006; 8: 86-94. (Pubitemid 43829485)
9. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev 2009; 227: 75-86.
10. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801. (Pubitemid 43261452)
11. Meylan E, Tschopp J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol Cell 2006; 22: 561-569. (Pubitemid 43817607)
12. Alnemri ES. Sensing cytoplasmic danger signals by the inflammasome. J Clin Immunol 2010; 30: 512-519.
13. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832.
14. Alexopoulou L, Holt AC, Medzhitov R et al. Recognition of doublestranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-738. (Pubitemid 33009951)
15. Pichlmair A, Schulz O, Tan CP et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 50-phosphates. Science 2006; 314: 997-1001. (Pubitemid 44749946)
16. Anders HJ, Lichtnekert J, Allam R. Interferon-alpha and-beta in kidney inflammation. Kidney Int 2010; 77: 848-854.
17. Kato H, Sato S, Yoneyama M et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005; 23: 19-28. (Pubitemid 41019654)
18. Yoneyama M, Kikuchi M, Matsumoto K et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005; 175: 2851-2858. (Pubitemid 41170502)
19. Hornung V, Ellegast J, Kim S et al. 50-Triphosphate RNA is the ligand for RIG-I. Science 2006; 314: 994-997.
20. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009; 138: 576-591.
21. Benigni A, Caroli C, Longaretti L et al. Involvement of renal tubular Tolllike receptor 9 in the development of tubulointerstitial injury in systemic lupus. Arthritis Rheum 2007; 56: 1569-1578. (Pubitemid 46764086)
22. Matsumoto M, Kikkawa S, Kohase M et al. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 2002; 293: 1364-1369. (Pubitemid 34681026)
23. Matsumoto M, Funami K, Oshiumi H et al. Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol Immunol 2004; 48: 147-154. (Pubitemid 38405076)
24. Yamamoto M, Sato S, Hemmi H et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003; 301: 640-643. (Pubitemid 36927946)
25. Johnsen IB, Nguyen TT, Ringdal M et al. Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J 2006; 25: 3335-3346. (Pubitemid 44141791)
26. West J, Damania B. Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol 2008; 82: 5440-5449. (Pubitemid 351705251)
27. Zhang SY, Jouanguy E, Ugolini S et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317: 1522-1527. (Pubitemid 47417427)
28. Préhaud C, Mégret F, Lafage M et al. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J Virol 2005; 79: 12893-12904. (Pubitemid 41433208)
29. Tabeta K, Georgel P, Janssen E et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 2004; 101: 3516-3521. (Pubitemid 38338227)
30. Wö rnle M, Schmid H, Banas B et al. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 2006; 168: 370-385. (Pubitemid 43271137)
31. Thornberry NA, Bull HG, Calaycay JR et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768-774.
32. Pé trilli V, Dostert C, Muruve DA et al. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007; 19: 615-622. (Pubitemid 350236810)
33. Fernandes-Alnemri T, Yu JW, Datta P et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009; 458: 509-513.
34. Ramos E, Drachenberg CB, Wali R et al. The decade of polyomavirus BKassociated nephropathy: state of affairs. Transplantation 2009; 87: 621-630.
35. Johnston O, Jaswal D, Gill JS et al. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation 2010; 89: 1057-1070.
36. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006; 7: 131-137. (Pubitemid 43135878)
37. Fried AH. Density heterogeneity of simian virus 40 ribonucleic acid late after infection of permissive cells. J Virol 1972; 10: 1236-1239.
38. Aloni Y. Extensive symmetrical transcription of Simian Virus 40 DNA in virus-yielding cells. Proc Natl Acad Sci USA 1972; 69: 2404-2409.
39. Schmid H, Nitschko H, Gerth J et al. Polyomavirus DNA and RNA detection in renal allograft biopsies: results from a European multicenter study. Transplantation 2005; 80: 600-604. (Pubitemid 41377745)
40. Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann NY Acad Sci 2008; 1143: 1-20.
41. Yoneyama M, Fujita T. RNA recognition and signal transduction by RIG-Ilike receptors. Immunol Rev 2009; 227: 54-65.
42. Negishi H, Osawa T, Ogami K et al. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci USA 2008; 105: 20446-20451.
43. Mannon RB, Hoffmann SC, Kampen RL et al. Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant 2005; 5: 2883-2893. (Pubitemid 43923948)
44. Kato H, Takeuchi O, Mikamo-Satoh E et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008; 205: 1601-1610. (Pubitemid 351962024)
45. Schmouder RL, Strieter RM, Wiggins RC et al. In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int 1992; 41: 191-198.
46. Schmouder RL, Strieter RM, Kunkel SL. Interferon-gamma regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide-1. Kidney Int 1993; 44: 43-49. (Pubitemid 23198024)
47. Daha MR, van Kooten C. Is the proximal tubular cell a proinflammatory cell? Nephrol Dial Transplant 2000; 15(Suppl 6): 41-43.
48. Rybka K et al. Immunocytological urinalysis and monocyte chemotactic peptide-1 in renal transplant recipients with polyomavirus replication. Transplant Proc 2006; 38: 151-154.
49. Low J, Humes HD, Szczypka M et al. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 2004; 323: 182-188. (Pubitemid 38748466)
50. Abend JR, Low JA, Imperiale MJ. Global effects of BKV infection on gene expression in human primary kidney epithelial cells. Virology 2010; 397: 73-79.
51. Newcomb DC, Sajjan U, Nanua S et al. Phosphatidylinositol 3-kinase is required for rhinovirus-induced airway epithelial cell interleukin-8 expression. J Biol Chem 2005; 280: 36952-36961. (Pubitemid 41587778)
52. Griego SD, Weston CB, Adams JL et al. Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J Immunol 2000; 165: 5211-5220.
53. Ablasser A, Bauernfeind F, Hartmann G et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009; 10: 1065-1072.
54. Bü rckstümmer T, Baumann C, Blüml S et al. An orthogonal proteomicgenomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009; 10: 266-272.
55. Cohen CD, Frach K, Schlö ndorff D et al. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int 2002; 61: 133-140. (Pubitemid 34075139)
56. Kessenbrock K, Krumbholz M, Schönermarck U et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009; 15: 623-625.
57. Prié D, Friedlander G, Coureau C et al. Role of adenosine on glucagoninduced cAMP in a human cortical collecting duct cell line. Kidney Int 1995; 47: 1310-1318.
58. Schmidt A, Schwerd T, Hamm W et al. 50-triphosphate RNA requires basepaired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci USA 2009; 106: 12067-12072.
59. Matsukura S, Kokubu F, Kurokawa M et al. Role of RIG-I, MDA-5, and PKR on the expression of inflammatory chemokines induced by synthetic dsRNA in airway epithelial cells. Int Arch of Allergy Immunol 2007; 143: 80-83. (Pubitemid 46854798)